THRESHOLD PHARMACEUTICALS INC (THLD) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 381 transactions totaling $209.8M, demonstrating a bearish sentiment with -$166.8M in net insider flow. The most recent transaction on Jun 1, 2017 involved a purchase of 473,077 shares valued at $269.7K.
No significant insider buying has been recorded for THLD in the recent period.
No significant insider selling has been recorded for THLD in the recent period.
Based on recent SEC filings, insider sentiment for THLD is bearish with an Insider Alignment Score of 10/100 and a net flow of -$166.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at THRESHOLD PHARMACEUTICALS INC (THLD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading THLD stock, having executed 381 transactions in the past 90 days. The most active insider is Vi, L.p. Fhm (Executive), who has made 6 transactions totaling $80.7M.
Get notified when executives and directors at THLD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 1, 2017 | W. Bird Jeffrey | Executive | Purchase | 473,077 | $0.57 | $269.7K | |
| Jun 1, 2017 | W. Bird Jeffrey | Executive | Purchase | 37,626 | $0.57 | $21.4K | |
| May 31, 2017 | W. Bird Jeffrey | Executive | Other | 630,770 | $N/A | $0 | |
| Mar 1, 2016 | W. Bird Jeffrey | Executive | Other | 617,132 | $N/A | $0 | |
| Mar 1, 2016 | W. Bird Jeffrey | Executive | Other | 96,010 | $N/A | $0 | |
| Nov 24, 2015 | E. Jaeger Wilfred | Executive | Other | 27,500 | $N/A | $0 | |
| Sep 28, 2015 | A. Fernandes Joel | Executive | Purchase | 3,562 | $3.96 | $14.1K | |
| Mar 18, 2015 | Gc Parker George | Executive | Option Exercise | 2,500 | $1.30 | $3.3K | |
| Feb 18, 2015 | E. Jaeger Wilfred | Executive | Purchase | 25,000 | $3.75 | $93.8K | |
| Oct 13, 2014 | Davar Nipun | Executive | Purchase | 3,000 | $2.99 | $9.0K | |
| Oct 2, 2014 | E. Selick Harold | Executive | Exercise | 20,942 | $2.05 | $42.9K | |
| Oct 1, 2014 | Ventures Sutter Hill | Executive | Exercise | 417,050 | $2.05 | $855.0K | Large |
| Oct 1, 2014 | Ventures Sutter Hill | Executive | Sale | 226,657 | $3.77 | $854.5K | Large |
| Oct 1, 2014 | L. Anderson David | Executive | Sale | 2,995 | $3.77 | $11.3K | |
| Oct 1, 2014 | L. Anderson David | Executive | Sale | 2,995 | $3.77 | $11.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 160 | $188.3M | 72.3% |
Exercise (Options)(X) | 64 | $33.2M | 12.8% |
Purchase(P) | 77 | $21.5M | 8.2% |
Other(J) | 47 | $17.3M | 6.6% |
Exercise(M) | 12 | $193.6K | 0.1% |
Award(A) | 1 | $7.7K | 0.0% |
Gift(G) | 20 | $0 | 0.0% |
Insider selling pressure at THRESHOLD PHARMACEUTICALS INC has increased, with 31 insiders executing 381 transactions across all time. Total sales of $188.3M significantly outpace purchases of $21.5M, resulting in a net outflow of $166.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.